Author

Justin L. Cope

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:machine learning (classical)· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Charles N. J. RavaraniiD· 2 shared Hannes A. BaukmanniD· 2 shared Marco Florian SchmidtiD· 2 shared Alexander R. E. C. Schwinges· 1 shared Colin BannardiD· 1 shared Erwin P. BöttingeriD· 1 shared Joern E. Klinger· 1 shared Jörn Klinger· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Charles N. J. RavaraniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Interaction-based feature selection algorithm outperforms polygenic risk score in predicting Parkinson's Disease status

Jörn Klinger, Charles N. J. Ravarani, Hannes A. Baukmann, Justin L. Cope, Erwin P. Böttinger, Stefan Konigorski, Marco Florian Schmidt

The paper presents an interaction-based feature selection algorithm that outperforms polygenic risk scores in predicting Parkinson's Disease status using the PPMI dataset.

Frontiers in Genetics · Oct 20, 2021Peer-reviewedGenetic & Genomic Medicine

Neutrophils cause critical illness in COVID-19 and reveal CDK6 inhibitors as potential treatment

Hannes A. Baukmann, Justin L. Cope, Charles N. J. Ravarani, Colin Bannard, Margaretha R. J. Lamparter, Alexander R. E. C. Schwinges, Joern E. Klinger, Marco Florian Schmidt

The paper identifies high neutrophil count as a causal trait in severe COVID-19 and suggests CDK6 inhibitors as potential treatment.

medRxiv · May 18, 2021 · PreprintGenetic & Genomic Medicine